Academic Highlights: A Roadmap to Key Pharmacologic Principles in Using Antipsychotics in the Treatment of Older Patients
J Clin Psychiatry 2009;70(1):131-138
© Copyright 2016 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Click to enlarge page
Antipsychotics are widely used to treat psychiatric disorders in older patients. While the growing number of second-generation antipsychotics (SGAs) has increased options for patients, it has also complicated clinical decision-making. Data from the American Psychiatric Association’s (APA’s) Practice Research Network indicated disproportionately high use of antipsychotics and benzodiazepine medications among older patients compared with those under age 65.